Samuel Whiting - 03 Jan 2024 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Chief Medical Officer
Signature
/s/ Nicholas Maestas, Attorney-in-Fact
Issuer symbol
TPST
Transactions as of
03 Jan 2024
Net transactions value
$0
Form type
4
Filing time
05 Jan 2024, 16:40:01 UTC
Previous filing
13 Oct 2023
Next filing
03 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Employee Stock Option (right to buy) Award $0 +100,000 $0.000000 100,000 03 Jan 2024 Common Stock 100,000 $4.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest in a series of 48 equal monthly installments measured from January 3, 2024, subject to the Reporting Person's continued service.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney